All CRMD Content

Breaking News

CorMedix (CRMD) reports higher Q4 2025 net profit on strong revenue growth

Biopharmaceutical company CorMedix Inc. (NASDAQ: CRMD) reported a sharp increase in revenues for the fourth quarter of fiscal 2025, primarily...

March 5, 20262 min read

CorMedix Inc (CRMD) CORMEDIX INC. TO REPORT THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 9

CorMedix Inc (NASDAQ: CRMD) Q3 2021 Earnings Conference

November 8, 20211 min read

CorMedix Inc (CRMD) Q2 2020 Earnings Call

CorMedix Inc (NASDAQ: CRMD) Q2 2020 Earnings Conference

August 2, 20211 min read

CorMedix Inc (CRMD) CORMEDIX INC. TO REPORT FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MAY 13

CorMedix Inc (NYSE MKT: CRMD) Q1 2021 Earnings Conference

May 13, 20211 min read

CorMedix Inc (CRMD) Q4 2020 Earnings Call Transcript

CorMedix Inc (NASDAQ: CRMD) Q4 2020 earnings call dated Mar. 30, 2021. Corporate Participants: Dan Ferry — Investor Relations Khoso Baluch — Chief Executive Officer Phoebe Mounts — Executive Vice President…

March 30, 202127 min read

CorMedix Inc (CRMD) CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

CorMedix Inc (NYSE MKT: CRMD) Q4 2020 Earnings Conference

March 26, 20211 min read

Market News

CorMedix (NYSE: CRMD): Q4 2019 Earnings Snapshot

— CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per share expected. — The latest…

March 16, 20202 min read

Market News

CorMedix, Inc. (NYSE: CRMD): Q3 2019 Earnings Snapshot

— CorMedix, Inc. (NYSE: CRMD) reported a net loss attributable to common shareholders of $32.4 million or $1.35 per share for the third quarter, compared…

November 14, 20191 min read